Artificial Intelligence in Breast Cancer Screening: Evaluation of FDA Device Regulation and Future Recommendations.

Potnis, Kunal C; Ross, Joseph S; Aneja, Sanjay; Gross, Cary P; Richman, Ilana B

Potnis, Kunal C; Ross, Joseph S; Aneja, Sanjay; Gross, Cary P; Richman, Ilana B.

Potnis KC; Yale School of Medicine, New Haven, Connecticut.
Ross JS; Section of General Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut.
Aneja S; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut.
Gross CP; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.
Richman IB; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut.

JAMA Intern Med ; 182(12): 1306-1312, 2022 12 01.

Article en En | MEDLINE | ID: mdl-36342705

Asunto(s)

Neoplasias de la Mama; Aprobación de Recursos; Estados Unidos; Humanos; Femenino; United States Food and Drug Administration; Inteligencia Artificial; Detección Precoz del Cáncer; Neoplasias de la Mama/diagnóstico por imagen; Estudios Retrospectivos; Estudios Multicéntricos como Asunto

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Aprobación de Recursos Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Screening_studies Límite: Female / Humans País como asunto: America do norte Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google